National Resilience, Inc. agreed to acquire West Chester site in Ohio from AstraZeneca PLC (LSE:AZN) on November 29, 2022. National Resilience, Inc will acquire the West Chester site’s operations and physical assets, retain the site’s leadership and employees, and continue to invest in the workforce and facility. AstraZeneca expects to complete the sale in the first quarter of 2023, subject to receipt of regulatory approvals and the satisfaction of other customary closing conditions. Stephen Infante of Covington & Burling LLP acted as legal advisor to AstraZeneca PLC (LSE:AZN). Christopher J. Wu, Garry J. Padrta, Joanna Schlingbaum, David MacDonald and Albert W. Stemp of Kirkland & Ellis LLP acted as a legal advisor to National Resilience, Inc.

National Resilience, Inc. completed the acquisition of West Chester site in Ohio from AstraZeneca PLC (LSE:AZN) on January 30, 2023.